Evidence map›Paper›PMID 41983529›Full record

ArticleCell biology international2026

TDP43 and hnRNP K Regulate Alternative Splicing of DNAJC5.

Helder Y Nagasse, Ellen K Okuda, Patricia P Coltri

Abstract read
In one paragraph

Article in Cell biology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Helder Y NagasseDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0001-7897-3556
Ellen K OkudaInstitute of Molecular Biosciences, Goethe University, Frankfurt am Main, Hesse, Germany.ORCID https://orcid.org/0009-0008-7704-2125
Patricia P ColtriDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0001-8447-7516

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/21874-5
6 · The paper itself

Abstract

Alternative splicing is a finely regulated process which defines the final maturation of pre-mRNAs. Modulation of trans-acting spliceosome proteins changes specific patterns of splicing and contributes to the development of diseases. During Amyotrophic Lateral Sclerosis (ALS) disease progression, loss of nuclear trans-acting splicing protein TDP43 leads to accumulation of cryptic exons in mRNAs, which inhibits expression of proteins and aggravates the disease. One of the affected genes is DNAJC5, which codes for a protein responsible for clearance of misfolded proteins in the cytoplasm. We first observed that TDP43 knockdown regulates DNAJC5 transcript splicing. A similar phenotype was observed upon hnRNP K knockdown. We hypothesized canonical splicing of DNAJC5 is dependent on the activity of both TDP43 and hnRNP K. Our results confirmed TDP43 and hnRNP K interaction is dependent on RNA. We also confirmed that DNAJC5 canonical splicing is dependent on its internal TDP43 and hnRNP K binding sites. Taken together, our work enrolls both TDP43 and hnRNP K on splicing regulation of DNAJC5 transcript, affecting activity of the protein encoded by DNAJC5 on endosomal traffic. As a result, activity of both TDP43 and hnRNP K and their association are important for ALS progression.

Indexed as

Alternative SplicingDNA-Binding ProteinsHeterogeneous-Nuclear Ribonucleoprotein KAmyotrophic Lateral SclerosisHEK293 CellsHumansRNA, MessengerDNA-Binding ProteinsHeterogeneous-Nuclear Ribonucleoprotein KHNRNPK protein, humanRNA, MessengerTARDBP protein, humanalternative splicingamyotrophic lateral sclerosisDNAJC5 proteinHNRNPK proteinTARDBP protein

Identifiers

PMID41983529
PMCPMC13081507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.